MDR-1703

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMDR-1703
Drug Alias NameMDR-1703
ClassificationBiologics
Mechanisms of ActionGlutaminyl-peptide cyclotransferase inhibitors
TargetsGlutaminyl-peptide cyclotransferase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedifron
China Registration ClassN/A

Develop Information

Active CompaniesMedifron
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A